查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1701272

周邊神經損傷市場規模、佔有率、趨勢分析報告：按產品、手術、應用、地區、細分市場預測，2025-2030

Peripheral Nerve Injury Market Size, Share & Trends Analysis Report By Product (Nerve Conduit, Nerve Protector), By Surgery (Direct Nerve Repair, Nerve Grafting, Stem Cell Therapy), By Application, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 110 Pages | 商品交期: 2-10個工作天內

價格

周邊神經損傷市場的成長和趨勢：

根據Grand View Research, Inc.的最新報告，全球周邊神經損傷市場規模預計到2030年將達到25.8億美元，預計2025年至2030年期間的複合年成長率為7.80%。

COVID-19 正在對市場產生不利影響，直接影響需求和生產，擾亂供應鏈並增加企業的財務負擔。在疫情期間，許多手術被例行性推遲和/或取消，以防止 COVID-19 的傳播。受災最嚴重的國家包括美國、俄羅斯、印度、巴西、法國、英國、義大利和西班牙，神經外科手術量下降了55%。

此外，由於全國封鎖，生物材料的製造活動、供應鏈、交貨計劃和銷售都受到干擾。展望未來，隨著產業參與者採用更新、更好的技術，預計該產業將在預測期內實現成長。例如，2022 年 5 月，Axogen, Inc. 揭露了 Axogen 的 RECON 臨床試驗的主要結果，該試驗比較了 Conduit 與 Avance 神經移植在數位神經損傷中的應用，Axogen, Inc. 是 PNI 突破性手術解決方案的行銷和開發領域的全球先驅。在第 3 階段關鍵研究中，實現了恢復靜態兩點辨別定義的感覺功能的主要目標，安全性與先前報告的資料相當。這些資訊可能有助於該公司在 2023 年下半年提交生技藥品核准申請 (BLA)。

周邊神經損傷市場報告重點

  • 神經導管預計將引領市場，2024 年的收入佔有率將超過 64.30%。
  • 直接神經修復領域預計將引領市場，到 2024 年將佔全球收入的 53.26% 以上。
  • 上肢部分在 2024 年佔據了最大的市場佔有率，預計在 2025 年至 2030 年期間將以最快的複合年成長率進一步成長。
  • 2024 年，北美佔據市場的最大收益佔有率，超過 30.43%。

目錄

第1章調查方法與範圍

第2章執行摘要

3. 周邊神經損傷市場變數、趨勢和範圍

  • 市場展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 周邊神經損傷市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第4章周邊神經損傷市場：產品估計與趨勢分析

  • 定義和範圍
  • 2024年及2030年的產品市場佔有率
  • 細分儀表板
  • 周邊神經損傷市場（按產品）展望
  • 2018年至2030年市場規模、預測及趨勢分析
    • 神經導管
    • 神經保護劑
    • 神經連接器
    • 神經繃帶

第5章周邊神經損傷市場：手術估計與趨勢分析

  • 定義和範圍
  • 2024年及2030年外科手術市場佔有率
  • 細分儀表板
  • 周邊神經損傷市場：外科手術展望
  • 2018年至2030年市場規模、預測及趨勢分析
    • 直接神經修復
    • 神經移植
    • 幹細胞療法

第6章周邊神經損傷市場：應用評估與趨勢分析

  • 定義和範圍
  • 2024 年和 2030 年應用市場佔有率
  • 細分儀表板
  • 周邊神經損傷市場：應用前景
  • 2018年至2030年市場規模、預測及趨勢分析
    • 上肢
    • 下肢

第7章周邊神經損傷市場：區域估計與趨勢分析

  • 2024 年及 2030 年區域市場佔有率分析
  • 區域市場儀表板
  • 全球區域市場概況
  • 區域市場佔有率和主要參與者（2024年）
  • 2018年至2030年市場應用、預測與趨勢分析：
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 印度
    • 中國
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章競爭格局

  • 主要市場參與企業的近期趨勢和影響分析
  • 公司/競爭對手分類
    • 創新者
  • 供應商格局
    • 主要經銷商和通路合作夥伴名單
    • 主要客戶
    • 主要企業市場佔有率分析（2024年）
    • AxoGen, Inc.
    • Stryker
    • Baxter International, Inc.
    • Polyganics BV
    • Integra LifeSciences
    • Renerva, LLC.
    • Newrotex
    • Toyobo Co., Ltd.
    • Orthocell Ltd
Product Code: GVR-4-68039-957-2

Peripheral Nerve Injury Market Growth & Trends:

The global peripheral nerve injury market size is estimated to reach USD 2.58 billion by 2030, registering to grow at a CAGR of 7.80% from 2025 to 2030 according to a new report by Grand View Research, Inc. COVID-19 has had a negative impact on the market, affecting the demand and production directly, disrupting the supply chain, and increasing the financial burden on businesses. During the pandemic, a number of surgeries were regularly postponed and/or canceled to prevent the spread of COVID-19. Neurosurgical procedures decreased by 55% in the worst-hit countries, including the U.S., Russia, India, Brazil, France, the U.K., Italy, and Spain.

Furthermore, manufacturing activities, supply chain, delivery schedules, and sale of biomaterials were disrupted due to nationwide lockdowns. Moving forward, as industry players are introducing new and better technologies, the industry is expected to grow over the forecast period. For instance, in May 2022, the topline results of Clinical Study Axogen's RECON comparing conduits to Avance Nerve Graft in digital nerve injuries were disclosed by Axogen, Inc., a global pioneer in marketing and developing revolutionary surgical solutions for PNIs. The primary target for the recovery of sensory function, as defined by static two-point discrimination, was fulfilled in Phase 3 pivotal research, and the safety profile was comparable with previously reported data. This information will help the company submit a Biologics License Application (BLA) in the second half of 2023.

Peripheral Nerve Injury Market Report Highlights:

  • The nerve conduit led the market and accounted for a more than 64.30% revenue share in 2024.
  • The direct nerve repair segment led the market and accounted for more than 53.26% share of the global revenue in 2024.
  • The upper extremities segment accounted for the largest market share in 2024 and is anticipated to grow further at the fastest CAGR from 2025 to 2030.
  • North America held the largest revenue share of more than 30.43% in the market in 2024.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
      • 1.3.5.1. Data for primary interviews in North America
      • 1.3.5.2. Data for primary interviews in Europe
      • 1.3.5.3. Data for primary interviews in Asia Pacific
      • 1.3.5.4. Data for primary interviews in Latin America
      • 1.3.5.5. Data for Primary interviews in MEA
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
      • 1.6.1.1. Approach 1: Commodity flow approach
    • 1.6.2. Volume price analysis (Model 2)
      • 1.6.2.1. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Surgery outlook
    • 2.2.3. Application outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Peripheral Nerve Injury Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing government fundings and reimbursements
      • 3.2.1.2. Technological advancements
      • 3.2.1.3. Rising medical tourism
      • 3.2.1.4. Increasing demand for 3D bioprinting approach
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Lack of awareness in the patients for treatment of peripheral nerve injury
      • 3.2.2.2. High cost of the treatment and unavailability of trained medical personnel
  • 3.3. Peripheral Nerve Injury Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Peripheral Nerve Injury Market: Product Estimates & Trend Analysis

  • 4.1. Definitions and Scope
  • 4.2. Product Market Share, 2024 & 2030
  • 4.3. Segment Dashboard
  • 4.4. Peripheral Nerve Injury Market by Product Outlook
  • 4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.5.1. Nerve Conduit
      • 4.5.1.1. Nerve conduit market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.2. Nerve Protector
      • 4.5.2.1. Nerve protector market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.3. Nerve Connector
      • 4.5.3.1. Nerve connector market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.4. Nerve Wraps
      • 4.5.4.1. Nerve wraps market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. Peripheral Nerve Injury Market: Surgery Estimates & Trend Analysis

  • 5.1. Definitions and Scope
  • 5.2. Surgery Market Share, 2024 & 2030
  • 5.3. Segment Dashboard
  • 5.4. Peripheral Nerve Injury Market by Surgery Outlook
  • 5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 5.5.1. Direct Nerve Repair
      • 5.5.1.1. Direct nerve repair market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.2. Nerve Grafting
      • 5.5.2.1. Nerve grafting market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.3. Stem Cell Therapy
      • 5.5.3.1. Stem cell therapy market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. Peripheral Nerve Injury Market: Application Estimates & Trend Analysis

  • 6.1. Definitions and Scope
  • 6.2. Application Market Share, 2024 & 2030
  • 6.3. Segment Dashboard
  • 6.4. Peripheral Nerve Injury Market by Application Outlook
  • 6.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 6.5.1. Upper Extremities
      • 6.5.1.1. Upper extremities market estimates and forecast 2018 to 2030 (USD Million)
    • 6.5.2. Lower Extremities
      • 6.5.2.1. Lower extremities market estimates and forecast 2018 to 2030 (USD Million)

Chapter 7. Peripheral Nerve Injury Market: Regional Estimates & Trend Analysis

  • 7.1. Regional market share analysis, 2024 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Global Regional Market Snapshot
  • 7.4. Regional Market Share and Leading Players, 2024
  • 7.5. Market Application, & Forecasts and Trend Analysis, 2018 to 2030:
  • 7.6. North America
    • 7.6.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 7.6.2. U.S.
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Competitive scenario
      • 7.6.2.3. Regulatory framework
      • 7.6.2.4. Reimbursement scenario
      • 7.6.2.5. U.S. market estimates and forecasts, 2018 - 2030
    • 7.6.3. Canada
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Competitive scenario
      • 7.6.3.3. Regulatory framework
      • 7.6.3.4. Reimbursement scenario
      • 7.6.3.5. Canada market estimates and forecasts, 2018 - 2030
    • 7.6.4. Mexico
      • 7.6.4.1. Key country dynamics
      • 7.6.4.2. Competitive scenario
      • 7.6.4.3. Regulatory framework
      • 7.6.4.4. Reimbursement scenario
      • 7.6.4.5. Mexico market estimates and forecasts, 2018 - 2030
  • 7.7. Europe
    • 7.7.1. UK
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Competitive scenario
      • 7.7.1.3. Regulatory framework
      • 7.7.1.4. Reimbursement scenario
      • 7.7.1.5. UK market estimates and forecasts, 2018 - 2030
    • 7.7.2. Germany
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Competitive scenario
      • 7.7.2.3. Regulatory framework
      • 7.7.2.4. Reimbursement scenario
      • 7.7.2.5. Germany market estimates and forecasts, 2018 - 2030
    • 7.7.3. France
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Competitive scenario
      • 7.7.3.3. Regulatory framework
      • 7.7.3.4. Reimbursement scenario
      • 7.7.3.5. France market estimates and forecasts, 2018 - 2030
    • 7.7.4. Italy
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Competitive scenario
      • 7.7.4.3. Regulatory framework
      • 7.7.4.4. Reimbursement scenario
      • 7.7.4.5. Italy market estimates and forecasts, 2018 - 2030
    • 7.7.5. Spain
      • 7.7.5.1. Key country dynamics
      • 7.7.5.2. Competitive scenario
      • 7.7.5.3. Regulatory framework
      • 7.7.5.4. Reimbursement scenario
      • 7.7.5.5. Spain market estimates and forecasts, 2018 - 2030
    • 7.7.6. Denmark
      • 7.7.6.1. Key country dynamics
      • 7.7.6.2. Competitive scenario
      • 7.7.6.3. Regulatory framework
      • 7.7.6.4. Reimbursement scenario
      • 7.7.6.5. Denmark market estimates and forecasts, 2018 - 2030
    • 7.7.7. Sweden
      • 7.7.7.1. Key country dynamics
      • 7.7.7.2. Competitive scenario
      • 7.7.7.3. Regulatory framework
      • 7.7.7.4. Reimbursement scenario
      • 7.7.7.5. Sweden market estimates and forecasts, 2018 - 2030
    • 7.7.8. Norway
      • 7.7.8.1. Key country dynamics
      • 7.7.8.2. Competitive scenario
      • 7.7.8.3. Regulatory framework
      • 7.7.8.4. Reimbursement scenario
      • 7.7.8.5. Norway market estimates and forecasts, 2018 - 2030
  • 7.8. Asia Pacific
    • 7.8.1. Japan
      • 7.8.1.1. Key country dynamics
      • 7.8.1.2. Competitive scenario
      • 7.8.1.3. Regulatory framework
      • 7.8.1.4. Reimbursement scenario
      • 7.8.1.5. Japan market estimates and forecasts, 2018 - 2030
    • 7.8.2. India
      • 7.8.2.1. Key country dynamics
      • 7.8.2.2. Competitive scenario
      • 7.8.2.3. Regulatory framework
      • 7.8.2.4. Reimbursement scenario
      • 7.8.2.5. India market estimates and forecasts, 2018 - 2030
    • 7.8.3. China
      • 7.8.3.1. Key country dynamics
      • 7.8.3.2. Competitive scenario
      • 7.8.3.3. Regulatory framework
      • 7.8.3.4. Reimbursement scenario
      • 7.8.3.5. China market estimates and forecasts, 2018 - 2030
    • 7.8.4. South Korea
      • 7.8.4.1. Key country dynamics
      • 7.8.4.2. Competitive scenario
      • 7.8.4.3. Regulatory framework
      • 7.8.4.4. Reimbursement scenario
      • 7.8.4.5. South Korea market estimates and forecasts, 2018 - 2030
    • 7.8.5. Australia
      • 7.8.5.1. Key country dynamics
      • 7.8.5.2. Competitive scenario
      • 7.8.5.3. Regulatory framework
      • 7.8.5.4. Reimbursement scenario
      • 7.8.5.5. Australia market estimates and forecasts, 2018 - 2030
    • 7.8.6. Thailand
      • 7.8.6.1. Key country dynamics
      • 7.8.6.2. Competitive scenario
      • 7.8.6.3. Regulatory framework
      • 7.8.6.4. Reimbursement scenario
      • 7.8.6.5. Thailand market estimates and forecasts, 2018 - 2030
  • 7.9. Latin America
    • 7.9.1. Brazil
      • 7.9.1.1. Key country dynamics
      • 7.9.1.2. Competitive scenario
      • 7.9.1.3. Regulatory framework
      • 7.9.1.4. Reimbursement scenario
      • 7.9.1.5. Brazil market estimates and forecasts, 2018 - 2030
    • 7.9.2. Argentina
      • 7.9.2.1. Key country dynamics
      • 7.9.2.2. Competitive scenario
      • 7.9.2.3. Regulatory framework
      • 7.9.2.4. Reimbursement scenario
      • 7.9.2.5. Argentina market estimates and forecasts, 2018 - 2030
  • 7.10. MEA
    • 7.10.1. South Africa
      • 7.10.1.1. Key country dynamics
      • 7.10.1.2. Competitive scenario
      • 7.10.1.3. Regulatory framework
      • 7.10.1.4. Reimbursement scenario
      • 7.10.1.5. South Africa market estimates and forecasts, 2018 - 2030
    • 7.10.2. Saudi Arabia
      • 7.10.2.1. Key country dynamics
      • 7.10.2.2. Competitive scenario
      • 7.10.2.3. Regulatory framework
      • 7.10.2.4. Reimbursement scenario
      • 7.10.2.5. Saudi Arabia market estimates and forecasts, 2018 - 2030
    • 7.10.3. UAE
      • 7.10.3.1. Key country dynamics
      • 7.10.3.2. Competitive scenario
      • 7.10.3.3. Regulatory framework
      • 7.10.3.4. Reimbursement scenario
      • 7.10.3.5. UAE market estimates and forecasts, 2018 - 2030
    • 7.10.4. Kuwait
      • 7.10.4.1. Key country dynamics
      • 7.10.4.2. Competitive scenario
      • 7.10.4.3. Regulatory framework
      • 7.10.4.4. Reimbursement scenario
      • 7.10.4.5. Kuwait market estimates and forecasts, 2018 - 2030

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
    • 8.2.1. Innovators
  • 8.3. Vendor Landscape
    • 8.3.1. List of key distributors and channel partners
    • 8.3.2. Key customers
    • 8.3.3. Key company market share analysis, 2024
    • 8.3.4. AxoGen, Inc.
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Product benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. Stryker
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Product benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. Baxter International, Inc.
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Product benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. Polyganics BV
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Product benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. Integra LifeSciences
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Product benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. Renerva, LLC.
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Product benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. Newrotex
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Product benchmarking
      • 8.3.10.4. Strategic initiatives
    • 8.3.11. Toyobo Co., Ltd.
      • 8.3.11.1. Company overview
      • 8.3.11.2. Financial performance
      • 8.3.11.3. Product benchmarking
      • 8.3.11.4. Strategic initiatives
    • 8.3.12. Orthocell Ltd
      • 8.3.12.1. Company overview
      • 8.3.12.2. Financial performance
      • 8.3.12.3. Product benchmarking
      • 8.3.12.4. Strategic initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global peripheral nerve injury market, by region 2018 - 2030 (USD Million)
  • Table 4 Global peripheral nerve injury market, by product 2018 - 2030 (USD Million)
  • Table 5 Global peripheral nerve injury market, by application, 2018 - 2030 (USD Million)
  • Table 6 Global peripheral nerve injury market, by surgery 2018 - 2030 (USD Million)
  • Table 7 North America peripheral nerve injury market, by country, 2018 - 2030 (USD Million)
  • Table 8 North America peripheral nerve injury market, by product, 2018 - 2030 (USD Million)
  • Table 9 North America peripheral nerve injury, by application, 2018 - 2030 (USD Million)
  • Table 10 North America peripheral nerve injury market, by surgery, 2018 - 2030 (USD Million)
  • Table 11 U.S. peripheral nerve injury market, by product, 2018 - 2030 (USD Million)
  • Table 12 U.S. peripheral nerve injury, by application, 2018 - 2030 (USD Million)
  • Table 13 U.S. peripheral nerve injury market, by surgery, 2018 - 2030 (USD Million)
  • Table 14 Canada peripheral nerve injury market, by product, 2018 - 2030 (USD Million)
  • Table 15 Canada peripheral nerve injury market, by application, 2018 - 2030 (USD Million)
  • Table 16 Canada peripheral nerve injury market, by surgery, 2018 - 2030 (USD Million)
  • Table 17 Mexico peripheral nerve injury market, by product, 2018 - 2030 (USD Million)
  • Table 18 Mexico peripheral nerve injury market, by application, 2018 - 2030 (USD Million)
  • Table 19 Mexico peripheral nerve injury market, by surgery, 2018 - 2030 (USD Million)
  • Table 20 Europe peripheral nerve injury market, by country, 2018 - 2030 (USD Million)
  • Table 21 Europe peripheral nerve injury market, by product, 2018 - 2030 (USD Million)
  • Table 22 Europe peripheral nerve injury market, by application, 2018 - 2030 (USD Million)
  • Table 23 Europe peripheral nerve injury market, by surgery, 2018 - 2030 (USD Million)
  • Table 24 UK peripheral nerve injury market, by product, 2018 - 2030 (USD Million)
  • Table 25 UK peripheral nerve injury market, by application, 2018 - 2030 (USD Million)
  • Table 26 UK peripheral nerve injury market, by surgery, 2018 - 2030 (USD Million)
  • Table 27 Germany peripheral nerve injury market, by product, 2018 - 2030 (USD Million)
  • Table 28 Germany peripheral nerve injury market, by application, 2018 - 2030 (USD Million)
  • Table 29 Germany peripheral nerve injury market, by surgery, 2018 - 2030 (USD Million)
  • Table 30 France peripheral nerve injury market, by product, 2018 - 2030 (USD Million)
  • Table 31 France peripheral nerve injury market, by application, 2018 - 2030 (USD Million)
  • Table 32 France peripheral nerve injury market, by surgery, 2018 - 2030 (USD Million)
  • Table 33 Italy peripheral nerve injury market, by product, 2018 - 2030 (USD Million)
  • Table 34 Italy peripheral nerve injury market, by application, 2018 - 2030 (USD Million)
  • Table 35 Italy peripheral nerve injury market, by surgery, 2018 - 2030 (USD Million)
  • Table 36 Spain peripheral nerve injury market, by product, 2018 - 2030 (USD Million)
  • Table 37 Spain peripheral nerve injury market, by application, 2018 - 2030 (USD Million)
  • Table 38 Spain peripheral nerve injury market, by surgery, 2018 - 2030 (USD Million)
  • Table 39 Sweden peripheral nerve injury market, by product, 2018 - 2030 (USD Million)
  • Table 40 Sweden peripheral nerve injury market, by application, 2018 - 2030 (USD Million)
  • Table 41 Sweden peripheral nerve injury market, by surgery, 2018 - 2030 (USD Million)
  • Table 42 Norway peripheral nerve injury market, by product, 2018 - 2030 (USD Million)
  • Table 43 Norway peripheral nerve injury market, by application, 2018 - 2030 (USD Million)
  • Table 44 Norway peripheral nerve injury market, by surgery, 2018 - 2030 (USD Million)
  • Table 45 Denmark peripheral nerve injury market, by product, 2018 - 2030 (USD Million)
  • Table 46 Denmark peripheral nerve injury market, by application, 2018 - 2030 (USD Million)
  • Table 47 Denmark peripheral nerve injury market, by surgery, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific peripheral nerve injury market, by country, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific peripheral nerve injury market, by product, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific peripheral nerve injury market, by application, 2018 - 2030 (USD Million)
  • Table 51 Asia Pacific peripheral nerve injury market, by surgery, 2018 - 2030 (USD Million)
  • Table 52 China peripheral nerve injury market, by product, 2018 - 2030 (USD Million)
  • Table 53 China peripheral nerve injury market, by application, 2018 - 2030 (USD Million)
  • Table 54 China peripheral nerve injury market, by surgery, 2018 - 2030 (USD Million)
  • Table 55 India peripheral nerve injury market, by product, 2018 - 2030 (USD Million)
  • Table 56 India peripheral nerve injury market, by application, 2018 - 2030 (USD Million)
  • Table 57 India peripheral nerve injury market, by surgery, 2018 - 2030 (USD Million)
  • Table 58 South Korea peripheral nerve injury market, by product, 2018 - 2030 (USD Million)
  • Table 59 South Korea peripheral nerve injury market, by application, 2018 - 2030 (USD Million)
  • Table 60 South Korea peripheral nerve injury market, by surgery, 2018 - 2030 (USD Million)
  • Table 61 Australia peripheral nerve injury market, by product, 2018 - 2030 (USD Million)
  • Table 62 Australia peripheral nerve injury market, by application, 2018 - 2030 (USD Million)
  • Table 63 Australia peripheral nerve injury market, by surgery, 2018 - 2030 (USD Million)
  • Table 64 Thailand peripheral nerve injury market, by application, 2018 - 2030 (USD Million)
  • Table 65 Thailand peripheral nerve injury market, by surgery, 2018 - 2030 (USD Million)
  • Table 66 Thailand peripheral nerve injury market, by product, 2018 - 2030 (USD Million)
  • Table 67 Japan peripheral nerve injury market, by application, 2018 - 2030 (USD Million)
  • Table 68 Japan peripheral nerve injury market, by surgery, 2018 - 2030 (USD Million)
  • Table 69 Latin America peripheral nerve injury market, by country, 2018 - 2030 (USD Million)
  • Table 70 Latin America peripheral nerve injury market, by product, 2018 - 2030 (USD Million)
  • Table 71 Latin America peripheral nerve injury market, by application, 2018 - 2030 (USD Million)
  • Table 72 Latin America peripheral nerve injury market, by surgery, 2018 - 2030 (USD Million)
  • Table 73 Brazil peripheral nerve injury market, by product, 2018 - 2030 (USD Million)
  • Table 74 Brazil peripheral nerve injury market, by application, 2018 - 2030 (USD Million)
  • Table 75 Brazil peripheral nerve injury market, by surgery, 2018 - 2030 (USD Million)
  • Table 76 Argentina peripheral nerve injury market, by product, 2018 - 2030 (USD Million)
  • Table 77 Argentina peripheral nerve injury market, by application, 2018 - 2030 (USD Million)
  • Table 78 Argentina peripheral nerve injury market, by surgery, 2018 - 2030 (USD Million)
  • Table 79 Middle East & Africa peripheral nerve injury market, by country, 2018 - 2030 (USD Million)
  • Table 80 Middle East & Africa peripheral nerve injury market, by product, 2018 - 2030 (USD Million)
  • Table 81 Middle East & Africa peripheral nerve injury market, by application, 2018 - 2030 (USD Million)
  • Table 82 Middle East & Africa peripheral nerve injury market, by surgery, 2018 - 2030 (USD Million)
  • Table 83 South Africa peripheral nerve injury market, by product, 2018 - 2030 (USD Million)
  • Table 84 South Africa peripheral nerve injury market, by application, 2018 - 2030 (USD Million)
  • Table 85 South Africa peripheral nerve injury market, by surgery, 2018 - 2030 (USD Million)
  • Table 86 Saudi Arabia peripheral nerve injury market, by product, 2018 - 2030 (USD Million)
  • Table 87 South Arabia peripheral nerve injury market, by application, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia peripheral nerve injury market, by surgery, 2018 - 2030 (USD Million)
  • Table 89 UAE peripheral nerve injury market, by product, 2018 - 2030 (USD Million)
  • Table 90 UAE peripheral nerve injury market, by application, 2018 - 2030 (USD Million)
  • Table 91 UAE peripheral nerve injury market, by surgery, 2018 - 2030 (USD Million)
  • Table 92 Kuwait peripheral nerve injury market, by product, 2018 - 2030 (USD Million)
  • Table 93 Kuwait peripheral nerve injury market, by application, 2018 - 2030 (USD Million)
  • Table 94 Kuwait peripheral nerve injury market, by surgery, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Peripheral nerve injury market: Market snapshot
  • Fig. 9 Peripheral nerve injury market: Market segmentation
  • Fig. 10 Peripheral nerve injury market Strategy framework
  • Fig. 11 Parent market outlook
  • Fig. 12 Related/ancillary market outlook
  • Fig. 13 Peripheral nerve injury market driver impact
  • Fig. 14 Peripheral nerve injury market restraint impact
  • Fig. 15 Peripheral nerve injury market porter's five forces analysis
  • Fig. 16 Peripheral nerve injury market PESTEL analysis
  • Fig. 17 Peripheral nerve injury market segment dashboard
  • Fig. 18 Peripheral nerve injury market: Product movement Analysis
  • Fig. 19 Nerve conduit market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 20 Nerve protector market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 21 Nerve connector market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Nerve wraps market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Peripheral nerve injury market: Surgery movement Analysis
  • Fig. 24 Direct nerve repair market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Nerve grafting market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Stem cell therapy market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Peripheral nerve injury market: Application movement Analysis
  • Fig. 28 Upper extremities market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 Lower extremities market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 30 Global peripheral nerve injury market: Regional movement analysis
  • Fig. 31 Global peripheral nerve injury market: Regional outlook and key takeaways
  • Fig. 32 Global market share, by region
  • Fig. 33 North America market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 34 U.S. market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 35 Canada market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 36 Europe market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 37 UK market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 38 Germany market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 39 France market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 40 Italy market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 41 Spain market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 42 Denmark market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 43 Sweden market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 44 Norway market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 45 Asia Pacific market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 46 Japan market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 47 China market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 48 India market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 49 Australia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 50 Thailand market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 51 South Korea market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 52 Latin America market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 53 Brazil market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 54 Mexico market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 55 Argentina market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 56 Middle East and Africa. market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 57 South Africa market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 58 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 59 UAE market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 60 Kuwait market estimates and forecast, 2018 - 2030 (USD Million)